CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

Oral H1-antihistamines (AHs) are the most commonly used therapy to treat allergic rhinitis and chronic urticaria. Older, first-generation AHs (e.g. diphenhydramine, hydroxyzine) have significant and common side e...

Source: Allergy, Asthma and Clinical Immunology - October 1, 2019 Category: Allergy & Immunology Authors: Michael N. Fein, David A. Fischer, Andrew W. O ’Keefe and Gord L. Sussman Tags: Review Source Type: research